Literature DB >> 8385093

The activity of daptomycin on Enterococcus faecium protoplasts: indirect evidence supporting a novel mode of action on lipoteichoic acid synthesis.

M Boaretti1, P Canepari, M M Lleò, G Satta.   

Abstract

The effect of daptomycin, an acidic lipopeptide antibiotic active against Gram-positives, was studied in Enterococcus faecium protoplasts. This antibiotic killed 99% of the protoplasts within 60 minutes of treatment, while vancomycin was ineffective, thus excluding peptidoglycan synthesis as the only target of the action of daptomycin. As previously seen with whole cells, in protoplasts lipoteichoic acid synthesis was the earliest and most strongly inhibited among types of macro-molecular synthesis. Radioactive daptomycin tightly bound only to the cytoplasmic membrane, in which the enzymes involved in lipoteichoic acid synthesis are located. These conclusions strongly support our previous proposal that daptomycin, though active against peptidoglycan synthesis, primarily inhibits lipoteichoic acid synthesis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8385093     DOI: 10.1093/jac/31.2.227

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  14 in total

1.  Resistance studies with daptomycin.

Authors:  J A Silverman; N Oliver; T Andrew; T Li
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

Review 2.  Lipoteichoic acid and lipids in the membrane of Staphylococcus aureus.

Authors:  W Fischer
Journal:  Med Microbiol Immunol       Date:  1994-05       Impact factor: 3.402

3.  Biosynthesis of the glycolipid anchor in lipoteichoic acid of Staphylococcus aureus RN4220: role of YpfP, the diglucosyldiacylglycerol synthase.

Authors:  M Y Kiriukhin; D V Debabov; D L Shinabarger; F C Neuhaus
Journal:  J Bacteriol       Date:  2001-06       Impact factor: 3.490

4.  Impact of PrsA on membrane lipid composition during daptomycin-resistance-mediated β-lactam sensitization in clinical MRSA strains.

Authors:  Carla C C R de Carvalho; Agustina Taglialegna; Adriana E Rosato
Journal:  J Antimicrob Chemother       Date:  2021-12-24       Impact factor: 5.758

5.  Comparative mechanistic studies of brilacidin, daptomycin, and the antimicrobial peptide LL16.

Authors:  Bruk Mensa; Gabriella L Howell; Richard Scott; William F DeGrado
Journal:  Antimicrob Agents Chemother       Date:  2014-06-16       Impact factor: 5.191

6.  In vitro bactericidal activities of daptomycin against Staphylococcus aureus and Enterococcus faecalis are not mediated by inhibition of lipoteichoic acid biosynthesis.

Authors:  Valerie Laganas; Jeffrey Alder; Jared A Silverman
Journal:  Antimicrob Agents Chemother       Date:  2003-08       Impact factor: 5.191

7.  Correlation of daptomycin bactericidal activity and membrane depolarization in Staphylococcus aureus.

Authors:  Jared A Silverman; Nancy G Perlmutter; Howard M Shapiro
Journal:  Antimicrob Agents Chemother       Date:  2003-08       Impact factor: 5.191

8.  Effect of divalent cations on the structure of the antibiotic daptomycin.

Authors:  Steven W Ho; David Jung; Jennifer R Calhoun; James D Lear; Mark Okon; Walter R P Scott; Robert E W Hancock; Suzana K Straus
Journal:  Eur Biophys J       Date:  2007-10-30       Impact factor: 1.733

9.  Identification of daptomycin-binding proteins in the membrane of Enterococcus hirae.

Authors:  M Boaretti; P Canepari
Journal:  Antimicrob Agents Chemother       Date:  1995-09       Impact factor: 5.191

10.  Transcriptional profiling reveals that daptomycin induces the Staphylococcus aureus cell wall stress stimulon and genes responsive to membrane depolarization.

Authors:  Arunachalam Muthaiyan; Jared A Silverman; Radheshyam K Jayaswal; Brian J Wilkinson
Journal:  Antimicrob Agents Chemother       Date:  2007-12-17       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.